| |
|
|
|
Rigel Pharmaceuticals Inc.  
|
|
1.64 -0.05 (-0.03%) |
10-16 16:00 |
|
Open: |
1.69 |
Pre close: |
1.69 |
Target:
|
2.11
|
|
High: |
1.725 |
Low: |
1.625 |
Resistance:
|
1.81
1.94
|
|
Volume: |
2,271,193 |
Market Cap: |
275M |
Support:
|
1.60
1.33
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.66
 |
MACD |
MACD(12,26):
|
-0.04  |
|
MA(20): |
1.71 |
Signal(12,26,9): |
-0.04 |
|
MA(100): |
2.05 |
Stochastic Oscillator |
%K(14,3):
|
18.63 |
|
MA(250): |
2.28 |
%D(3): |
18.95 |
|
Average Volume(K) |
3-Month: |
134001
|
52-Week |
High:
|
3.29 |
|
10-Days: |
110441 |
Low: |
1.60 |
|
RSI |
RSI(14):
|
41.88 |
Change(%): |
-48.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.352 |
Return on Equity (ttm) |
-58.2 |
Shares Out. (M) |
167.61 |
|
EPS Est. Current Year |
-0.600 |
Return on Assets (ttm) |
-25.9 |
Shares Float (M) |
167.12 |
|
EPS Est. Next Year |
-0.430 |
PEG Ratio |
-0.08 |
% Held by Insiders |
0.25 |
|
EPS Est. Next Quarter |
-0.150 |
Qtrly Rev. Growth |
482.4 |
% Held by Institutions |
97.74 |
|
Forward EPS |
-0.470 |
Gross Profit (p.s.) |
-0.016 |
Shares Short (K) |
12840 |
|
Book Value (p.s.) |
0.470 |
EBITDA (p.s.) |
-0.363 |
P/E |
-4.66 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
3.49 |
|
Profit Margin |
-89.34 |
Operating Cash Flow
(M) |
-25.66 |
P/S |
704821568.00 |
|
Operating Margin |
-93.62 |
Levered Free Cash Flow
(M) |
-31.92 |
P/CF |
-10.71 |
|
|
|
|
|
|
